Home > Boards > Free Zone > Industry Specific > Israel Stock Ideas

Accelerated Evolution Biotechnologies

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gfp927z Member Profile
 
Followed By 60
Posts 21,270
Boards Moderated 62
Alias Born 03/22/05
160x600 placeholder
gfp927z   Tuesday, 01/29/19 04:58:52 PM
Re: None
Post # of 92 
Accelerated Evolution Biotechnologies

>>> Israeli scientists claim they'll have cancer cure in a year


By GINA SALAMONE

NEW YORK DAILY NEWS

JAN 29, 2019


https://www.nydailynews.com/life-style/health/ny-fea-cancer-cure-year-israeli-scientists-20190129-story.html


A group of Israeli scientists say they’ll have a cure for cancer within a year.

The treatment is being cooked up by Accelerated Evolution Biotechnologies Ltd. , a drug development company established in 2000, according to the Jerusalem Post.

“We believe we will offer in a year’s time a complete cure for cancer,” Dan Aridor, chairman of the board for AEBi, told the Post.

“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor added. “Our solution will be both generic and personal.”

The treatment is called MuTaTo, which stands for multi-target toxin, and is designed to act as a cancer antibiotic. MuTaTo uses several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that would kill cancer cells, according to the Post.

“We made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer,” Dr. Ilan Morad, CEO of AEBi, said. “The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used.

“Instead of attacking receptors one at a time, we attack receptors three at a time — not even cancer can mutate three receptors at the same time,” Morad added.

AEBi is about to begin clinical trials that will wrap up in a few years. “Our results are consistent and repeatable,” Aridor said.

<<<



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist